Aclaris Therapeutics to Attend September Healthcare Events

Author: Owen Jenkins Updated: 08-27-2025 08:18 AM

Aclaris Therapeutics Announces Participation in Upcoming Conferences

WAYNE, Pa. — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a promising clinical-stage biopharmaceutical company, is excited to announce its participation in two upcoming healthcare conferences throughout September. This involvement highlights the commitment of Aclaris to share its innovative developments with the healthcare community and potential investors.

Details of Conference Participation

On September 3, 2025, at 1:00 PM EDT, Aclaris' Chief Executive Officer, Dr. Neal Walker, along with the senior leadership team, will engage in a fireside chat during the esteemed Cantor Global Healthcare Conference. This event set in New York City provides a valuable platform for showcasing Aclaris’ strategic vision and progress in the biopharmaceutical space.

Insights at the H.C. Wainwright Conference

Following shortly, on September 9, 2025, at 9:00 AM EDT, Dr. Walker will present a corporate overview during the H.C. Wainwright 27th Annual Global Investment Conference. This event will allow Aclaris to delve deeper into their research and development strategies, and outline their goals surrounding novel product candidates aimed at treating immuno-inflammatory diseases.

Accessing Live Webcasts

For those interested in Aclaris’ presentations, live and archived webcasts of these events will be made available. Interested individuals can find the webcasts on the Aclaris website for a duration of at least 30 days following the events. This makes it accessible for a wider audience to stay informed regarding Aclaris Therapeutics’ advancements and initiatives.

About Aclaris Therapeutics, Inc.

Aclaris Therapeutics is dedicated to harnessing the potential of innovative treatments for patients suffering from immuno-inflammatory diseases. With a robust R&D pipeline, the company focuses on developing new solutions catering to patients who currently have limited treatment options. Their commitment is evident as they continuously strive to meet unmet medical needs through rigorous research and development.

Contact Information

If you have any inquiries or require further information about Aclaris Therapeutics, please reach out to:

Will Roberts
Senior Vice President
Corporate Communications and Investor Relations
(484) 329-2125
wroberts@aclaristx.com

Frequently Asked Questions

What is Aclaris Therapeutics known for?

Aclaris Therapeutics specializes in developing novel product candidates aimed at immuno-inflammatory diseases with insufficient treatment options.

Which conferences is Aclaris participating in?

Aclaris will participate in the Cantor Global Healthcare Conference and the H.C. Wainwright 27th Annual Global Investment Conference in September.

Who will represent Aclaris at these conferences?

Dr. Neal Walker, CEO of Aclaris, along with the senior leadership team, will represent the company during these key events.

How can I watch the Aclaris presentations?

You can access live and archived presentations on the Aclaris Therapeutics website for up to 30 days post-event.

Where can I find more information about Aclaris?

For detailed information, visit the Aclaris Therapeutics website at www.aclaristx.com.

About The Author

Hi there I'm 38-year-old author and financial consultant Owen Jenkins. Having worked in the financial sector for more than ten years, I am well-versed in the subtleties and complexity that mold our financial environment. Following a degree in finance, I worked in a number of financial institutions honing my abilities in market analysis, financial planning, and investment strategies.

My love is teaching others about investing and personal finance. My goal in writing many books and articles has been to demystify financial ideas and give readers the information they need to make wise financial decisions. I write with a direct, useful style that emphasizes doable suggestions for daily living.

Along with writing, I lead webinars and seminars where I impart knowledge on how to successfully negotiate the financial world. I also write for financial journals and show up as a guest expert on financial news programs a lot. Whether they are new to investing or want to improve their approach, my mission is to enable people to take charge of their financial futures.

Beyond work, I like to hike, play the guitar, and spend time with my family. I think that balance is crucial and want to encourage people to strike a balance between their financial aspirations and their hobbies. I want to help people succeed and achieve financial security through my work, so having a good influence.

Contact Owen Jenkins privately here. Or send an email with ATTN: Owen Jenkins as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.